Error: Could not add to watchlist. X

Anadys Pharmaceuticals Inc

+ Watchlist
ANDS:US
Acquired
ANDS:US was acquired by ROG:VX
USD
Volume
0
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.51
Market Cap (USD)
-
Shares Outstanding (m)
57.438
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Anadys Pharmaceuticals Inc. provides biopharmaceuticals. The Company discovers, develops, and commercializes small molecule, anti-infective medicines for the treatment of hepatitis C virus, or HCV, and bacterial infections.
ADDRESS
5871 Oberlin Drive
Suite 200
San Diego, CA 92121
United States
PHONE
1-858-530-3600
WEBSITE
-